Fund Holdings — SECTORAL ASSET MANAGEMENT INC

Total Portfolio Value:
$157.39M
Total Bought:
$43.40M
Total Sold:
$24.97M
Net Transaction:
+$18.44M
Notable People:
Jerome Georges Pfund
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Apnimed Inc0942,208+942,208$0$20.64M13.12%+$20.64M
Contineum TherapeuticsCL A727,587689,587-38,000$11.93M$9.25M5.88%-$2.67M
Shoulder Innovations430,407430,420+13$8.73M$8.13M5.17%-$593.7K
Eli Lilly and Company(LLY)6,3546,664+310$7.62M$7.71M4.90%+$89.6K
Johnson & Johnson(JNJ)18,21822,758+4,540$4.63M$6.02M3.83%+$1.40M
Vertex Pharmaceuticals Incorporated(VRTX)5,4327,532+2,100$2.70M$3.94M2.50%+$1.24M
Gilead Sciences, Inc.(GILD)20,62024,655+4,035$2.61M$3.67M2.33%+$1.07M
Amgen Inc.(AMGN)9,2107,860-1,350$3.34M$3.31M2.11%-$22.1K
AbbVie Inc.(ABBV)12,20012,300+100$3.07M$3.22M2.04%+$147.5K
DexCom, Inc.(DXCM)50,75637,231-13,525$3.42M$3.21M2.04%-$205.8K
Summit Therapeutics Inc.(SMMT)220,180177,180-43,000$3.21M$3.00M1.90%-$211.9K
Arcus Biosciences, Inc.(RCUS)110,870115,933+5,063$3.42M$2.99M1.90%-$423.6K
Merck & Co., Inc.(MRK)21,48020,460-1,020$2.77M$2.99M1.90%+$212.2K
BioNTech SEADR(BNTX)41,86930,185-11,684$3.90M$2.97M1.89%-$928.7K
Oruka Therapeutics, Inc.(ORKA)41,98735,349-6,638$4.00M$2.94M1.87%-$1.05M
Avalo Therapeutics Inc119,923177,294+57,371$2.22M$2.72M1.73%+$501.7K
Insmed Incorporated(INSM)23,21623,706+490$2.48M$2.71M1.72%+$230.5K
Arrivent Biopharma79,04387,343+8,300$2.75M$2.64M1.68%-$101.2K
Tango Therapeutics, Inc.(TNGX)0105,757+105,757$0$2.64M1.68%+$2.64M
argenx SEADR(ARGX)2,8312,676-155$2.63M$2.57M1.63%-$60.5K
iRhythm Holdings, Inc.(IRTC)26,07022,570-3,500$3.10M$2.57M1.63%-$535.7K
Alphatec Holdings, Inc.(ATEC)185,900246,150+60,250$1.61M$2.54M1.61%+$932.2K
Crescent Biopharma Inc.121,300167,600+46,300$2.18M$2.45M1.55%+$261.9K
Braveheart Bio Inc0119,743+119,743$0$2.42M1.54%+$2.42M
Intuitive Surgical, Inc.(ISRG)5,8505,869+19$2.33M$2.39M1.52%+$60.1K
UnitedHealth Group Incorporated(UNH)13,2356,208-7,027$5.50M$2.28M1.45%-$3.22M
Regeneron Pharmaceuticals, Inc.(REGN)2,1692,869+700$1.35M$2.18M1.38%+$823.0K
Stryker Corporation(SYK)7,1297,829+700$2.25M$2.16M1.37%-$88.0K
Danaher Corporation(DHR)9,5979,5970$1.83M$2.13M1.35%+$298.2K
Roivant Sciences Ltd.SHS(ROIV)61,10058,100-3,000$2.16M$2.12M1.35%-$37.6K
Immatics N.V.SHS(IMTX)224,928225,985+1,057$2.28M$1.98M1.26%-$294.4K
Thermo Fisher Scientific Inc.(TMO)3,5082,908-600$1.76M$1.96M1.25%+$204.3K
IQVIA Holdings Inc.(IQV)10,8487,014-3,834$2.10M$1.89M1.20%-$210.3K
Alnylam Pharmaceuticals, Inc.(ALNY)2,3107,385+5,075$695.4K$1.82M1.16%+$1.13M
Abbott Labs18,08018,0800$1.64M$1.79M1.14%+$146.3K
Tectonic Therapeutic71,00972,592+1,583$2.44M$1.69M1.07%-$750.3K
Pfizer Inc.(PFE)27,50057,500+30,000$662.2K$1.64M1.04%+$977.7K
uniQure N.V.SHS(QURE)062,425+62,425$0$1.51M0.96%+$1.51M
United Therapeutics Corporation(UTHR)1,3702,695+1,325$742.3K$1.46M0.93%+$718.1K
ABIVAX Société AnonymeADS(ABVX)2,34014,561+12,221$311.8K$1.44M0.92%+$1.13M
TransMedics Group, Inc.(TMDX)21,95015,950-6,000$1.46M$1.33M0.85%-$126.9K
Pulse Biosciences, Inc.(PLSE)67,89526,170-41,725$1.88M$1.31M0.83%-$576.3K
CVS Health Corporation(CVS)13,00013,041+41$1.34M$1.12M0.71%-$227.4K
Moderna, Inc.(MRNA)4,3505,300+950$304.6K$1.02M0.65%+$716.0K
Cytokinetics, Incorporated(CYTK)16,33015,289-1,041$1.39M$1.01M0.64%-$383.5K
Medtronic plcSHS(MDT)11,10011,1000$876.3K$965.8K0.61%+$89.5K
Vera Therapeutics, Inc.CL A(VERA)25,57328,573+3,000$1.10M$922.6K0.59%-$174.7K
Elevance Health, Inc.(ELV)02,006+2,006$0$780.0K0.50%+$780.0K
Bristol-Myers Squibb Company(BMY)21,15012,061-9,089$1.22M$752.6K0.48%-$466.1K
Centene Corporation(CNC)12,00012,040+40$770.3K$747.9K0.48%-$22.4K
Boston Scientific Corporation(BSX)36,33014,730-21,600$1.55M$643.0K0.41%-$907.6K
Nektar Therapeutics(NKTR)10,11110,1110$705.8K$612.2K0.39%-$93.7K
Edwards Lifesciences14,8266,804-8,022$1.34M$587.3K0.37%-$753.8K
Ascendis Pharma A/S(ASND)2,5702,5700$685.5K$585.5K0.37%-$99.9K
Illumina, Inc.(ILMN)2,1322,1320$374.9K$583.5K0.37%+$208.6K
BioMarin Pharmaceutical Inc.(BMRN)9,4509,4500$540.7K$567.0K0.36%+$26.3K
Revolution Medicines, Inc.(RVMD)1,8302,760+930$342.7K$566.5K0.36%+$223.8K
PTC Therapeutics, Inc.(PTCT)7,4708,570+1,100$609.3K$555.2K0.35%-$54.2K
Humana Inc.INC(HUM)1,2501,255+5$497.3K$478.9K0.30%-$18.4K
Royalty Pharma plcCL A(RPRX)7,2007,2000$403.7K$420.2K0.27%+$16.5K
Biogen Inc.(BIIB)1,8501,8500$399.7K$417.9K0.27%+$18.2K
Genmab A/SADS(GMAB)09,900+9,900$0$353.2K0.22%+$353.2K
Guardant Health, Inc.(GH)1,9801,9800$297.1K$353.2K0.22%+$56.1K
Ionis Pharmaceuticals, Inc.(IONS)7,2007,2000$570.9K$321.5K0.20%-$249.4K
Tempus AI, Inc.CL A(TEM)3,8803,8800$224.8K$317.8K0.20%+$93.0K
Oric Pharmaceuticals23,50023,5000$254.5K$316.5K0.20%+$62.0K
Incyte Corporation(INCY)2,3502,3500$266.4K$285.2K0.18%+$18.8K
Axsome Therapeutics, Inc.(AXSM)1,5001,5000$367.2K$276.6K0.18%-$90.6K
Newamsterdam Pharma Company
ORDINARY SHARES
09,500+9,500$0$231.0K0.15%+$231.0K
Ardelyx Inc122,39456,100-66,294$624.2K$191.9K0.12%-$432.3K
Corbus Pharmaceuticals Hldgs20,00028,000+8,000$187.6K$191.0K0.12%+$3.4K
Kura Oncology Inc71,48017,050-54,430$784.1K$182.6K0.12%-$601.5K
Ars Pharmaceuticals29,90040,300+10,400$239.5K$173.7K0.11%-$65.8K
Neurocrine Biosciences, Inc.(NBIX)01,150+1,150$0$163.1K0.10%+$163.1K
Alx Oncology Hldgs Inc090,000+90,000$0$125.1K0.08%+$125.1K
Palisade Bio Inc88,00088,0000$183.9K$118.8K0.08%-$65.1K
Eyepoint Inc023,700+23,700$0$77.5K0.05%+$77.5K
Engene Therapeutics Inc21,70021,7000$37.5K$43.4K0.03%+$5.9K
AgomAb Therapeutics NVADS(AGMB)43,5000-43,500$564.6K$0—-$564.6K
BeOne Medicines AGADR(ONC)1,8700-1,870$532.9K$0—-$532.9K
BridgeBio Pharma, Inc.(BBIO)4,1000-4,100$305.4K$0—-$305.4K
Cogent Biosciences, Inc.(COGT)26,7400-26,740$1.03M$0—-$1.03M
Definium Therapeutics, Inc.(DFTX)78,3100-78,310$3.68M$0—-$3.68M
Hinge Health, Inc.CL A(HNGE)8,7440-8,744$725.8K$0—-$725.8K
Medpace Holdings, Inc.(MEDP)4300-430$227.7K$0—-$227.7K
Mineralys Therapeutics, Inc.(MLYS)14,5650-14,565$393.0K$0—-$393.0K
Privia Health Group, Inc.(PRVA)24,1360-24,136$621.0K$0—-$621.0K
Structure TherapeuticsADR4,3250-4,325$232.1K$0—-$232.1K
Syndax Pharmaceuticals, Inc.(SNDX)15,6800-15,680$342.8K$0—-$342.8K
Tarsus Pharmaceuticals, Inc.(TARS)13,2850-13,285$836.2K$0—-$836.2K
Trevi Therapeutics, Inc.(TRVI)65,5960-65,596$1.22M$0—-$1.22M
Jazz Pharmaceuticals plcSHS USD(JAZZ)1,7500-1,750$421.7K$0—-$421.7K
Page 1 of 1
SECTORAL ASSET MANAGEMENT INC — 13F Holdings — Q3 2026 | TickerTrail